Skip to content
healthcare.dev
Get a free key

DANYELZA

NDC 50633-230, Naxitamab, injection, from BTG International Inc..

Product NDC
50633-230
Status
Listed
Labeler
BTG International Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761171
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50633-230 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAXITAMAB40 mg/10mL

Pharmacologic classes

Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]; Glycolipid Disialoganglioside-directed Antibody [EPC]

Package NDCNDC-11Package
50633-230-01506330230011 VIAL, SINGLE-DOSE in 1 CARTON (50633-230-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b0f5ee96-369f-4cb9-a783-3bfa70fe8f90

Use it

Look up 50633-230 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50633-230 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50633-230. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.